Sutro Biopharma, Inc. Common Stock (STRO)

Typically moves ±8.82% on earnings

EARNINGS ANALYTICS

event_note Approx. Next Earnings: ~2026-11-10 APPROXIMATE

Sutro Biopharma, Inc. Common Stock (STRO) has reported earnings 21 times since Aug 09, 2021. The stock moves an average of ±8.82% the day after reporting, closing higher 61.9% of the time. Its largest post-earnings gain was +27.83% (Mar 25, 2024) and its largest decline was -35.2% (Mar 13, 2025). The next earnings report is predicted for 2026-11-10 (approximate).

Earnings reactions

How STRO moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±8.82%

Positive %

61.9%

Negative %

38.1%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 12, 2026	☀ PRE	-15.03%	open_in_new
May 14, 2026	☽ POST	+1.61%	open_in_new
Mar 23, 2026	☽ POST	+11.32%	open_in_new
Nov 06, 2025	☽ POST	-14.2%	open_in_new
Aug 07, 2025	☽ POST	+0.15%	open_in_new
May 08, 2025	☽ POST	-8.33%	open_in_new
Mar 13, 2025	☽ POST	-35.2%	open_in_new
Nov 13, 2024	☽ POST	-12.85%	open_in_new
Aug 13, 2024	☽ POST	+11.18%	open_in_new
May 13, 2024	☽ POST	+4.7%	open_in_new
Mar 25, 2024	☽ POST	+27.83%	open_in_new
Nov 13, 2023	☽ POST	+14.01%	open_in_new
Aug 10, 2023	☽ POST	-2.19%	open_in_new
May 15, 2023	☀ PRE	+4.07%	open_in_new
Mar 30, 2023	☽ POST	+4.16%	open_in_new
Nov 08, 2022	☽ POST	+2.79%	open_in_new
Aug 08, 2022	☽ POST	+6.69%	open_in_new
May 09, 2022	☽ POST	+5.67%	open_in_new
Feb 28, 2022	☽ POST	-2.59%	open_in_new
Nov 10, 2021	☀ PRE	+0.19%	open_in_new
Aug 09, 2021	☀ PRE	-0.49%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±8.82%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 20 →

Funds holding

$93356151

Total value held

Buying

18 added · 0 reduced

Blackrock, Inc.

$37272146 +382.48%

State Street Corp

$10158503 +487.09%

Merck & Co., Inc.

$9042053 NEW BUY

Ameriprise Financial Inc

$8123011 NEW BUY

Ubs Group Ag

$6922599 NEW BUY

SEC Filing Types

description 4

9 chevron_right

description SCHEDULE 13G/A

description SCHEDULE 13G

2 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
10-Q	20260812	open_in_new SEC.gov
8-K	20260812	open_in_new SEC.gov
SCHEDULE 13G	20260730	open_in_new SEC.gov
4	20260609	open_in_new SEC.gov
4	20260609	open_in_new SEC.gov
4	20260609	open_in_new SEC.gov
4	20260609	open_in_new SEC.gov
4	20260609	open_in_new SEC.gov

Frequently asked about STRO earnings

When does Sutro Biopharma, Inc. Common Stock report earnings next? expand_more

Sutro Biopharma, Inc. Common Stock (STRO)'s next earnings date is approximate for 2026-11-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does STRO stock move after earnings? expand_more

Over 21 reports, STRO has moved an average of ±8.82% the session after earnings, closing higher 61.9% of the time.

What was STRO's biggest post-earnings move? expand_more

STRO's largest post-earnings gain on record was +27.83% on Mar 25, 2024, and its largest decline was -35.2% on Mar 13, 2025.

Where can I find Sutro Biopharma, Inc. Common Stock's SEC filings? expand_more

All of Sutro Biopharma, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.